Danaher (DHR) PT Raised to $290 at Barclays
Get Alerts DHR Hot Sheet
Price: $230.50 +0.33%
Rating Summary:
30 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
30 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Danaher (NYSE: DHR) to $290.00 (from $277.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Danaher (DHR) PT Raised to $260 at Stifel as Nonrespiratory Core Growth Exceeded Expectations
- Cepheid Earns Three 2026 IMV ServiceTrak⢠Clinical Laboratory Awards for Customer Satisfaction, Service, and System Performance
- Danaher (DHR) PT Raised to $254 at Baird
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share